The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zerlinda 4 mg/100 ml solution for infusion

Teva B.V.PA1986/119/001

Main Information

Trade NameZerlinda 4 mg/100 ml solution for infusion
Active SubstancesZoledronic acid
Dosage FormSolution for infusion
Licence HolderTeva B.V.
Licence NumberPA1986/119/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA08 zoledronic acid


License statusAuthorised
Licence Issued04/11/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see: Summary of Product Characteristics, section 4.2)
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - Patient

« Back